Xavier Matias-Guiu Guia
Degree: PhD
973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat
ResearcherID: http://www.researcherid.com/rid/C-3039-2009
Groups
Publications
-
Mateo, F; Arenas, EJ; Aguilar, H; Serra-Musach, J; de Garibay, GR; Boni, J; Maicas, M; Du, S; Iorio, F; Herranz-Ors, C; Islam, A; Prado, X; Llorente, A; Petit, A; Vidal, A; Catala, I; Soler, T; Venturas, G; Rojo-Sebastian, A; Serra, H; Cuadras, D; Blanco, I; Lozano, J; Canals, F; Sieuwerts, AM; de Weerd, V; Look, MP; Puertas, S; Garcia, N; Perkins, AS; Bonifaci, N; Skowron, M; Gomez-Baldo, L; Hernandez, V; Martinez-Aranda, A; Martinez-Iniesta, M; Serrat, X; Ceron, J; Brunet, J; Barretina, MP; Gil, M; Falo, C; Fernandez, A; Morilla, I; Pernas, S; Pla, MJ; Andreu, X; Segui, MA; Ballester, R; Castella, E; Nellist, M; Morales, S; Valls, J; Velasco, A; Matias-Guiu, X; Figueras, A; Sanchez-Mut, JV; Sanchez-Cespedes, M; Cordero, A; Gomez-Miragaya, J; Palomero, L; Gomez, A; Gajewski, TF; Cohen, EEW; Jesiotr, M; Bodnar, L; Quintela-Fandino, M; Lopez-Bigas, N; Valdes-Mas, R; Puente, XS; Viñals F; Casanovas, O; Graupera, M; Hernandez-Losa, J; Ramón Y Cajal S; Garcia-Alonso, L; Saez-Rodriguez, J; Esteller, M; Sierra, A; Martin-Martin, N; Matheu, A; Carracedo, A; Gonzalez-Suarez, E; Nanjundan, M; Cortes, J; Lazaro, C; Odero, MD; Martens, JWM; Moreno-Bueno, G; Barcellos-Hoff, MH; Villanueva, A; Gomis, RR; Pujana, MA
Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition
ONCOGENE 36 2737-2749. .
-
Maiques, O; Macia, A; Moreno, S; Barcelo, C; Santacana, M; Vea, A; Herreros, J; Gatius, S; Ortega, E; Valls, J; Chen, BJ; Llobet-Navas, D; Matias-Guiu, X; Canti, C; Marti, RM
Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma
BRITISH JOURNAL OF DERMATOLOGY 176 1247-1258. .
-
Piulats, JM; Guerra, E; Gil-Martin, M; Roman-Canal, B; Gatius, S; Sanz-Pamplona, R; Velasco, A; Vidal, A; Matias-Guiu, X
Molecular approaches for classifying endometrial carcinoma
GYNECOLOGIC ONCOLOGY 145 200-207. .
-
Garcia-Sanz, P; Triviño JC; Mota, A; Perez Lopez, M; Colas, E; Rojo-Sebastian, A; Garcia, A; Gatius, S; Ruiz, M; Prat, J; Lopez-Lopez, R; Abal, M; Gil-Moreno, A; Reventos, J; Matias-Guiu, X; Moreno-Bueno, G
Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma
INTERNATIONAL JOURNAL OF CANCER 140 1551-1563. .
-
Mancikova, V; Montero-Conde, C; Perales-Paton, J; Fernandez, A; Santacana, M; Jodkowska, K; Inglada-Perez, L; Castelblanco, E; Borrego, S; Encinas, M; Matias-Guiu, X; Fraga, M; Robledo, M
Multilayer OMIC Data in Medullary Thyroid Carcinoma Identifies the STAT3 Pathway as a Potential Therapeutic Target in RETM918T Tumors
CLINICAL CANCER RESEARCH 23 1334-1345. .
-
Devis, L; Moiola, CP; Masia, N; Martinez-Garcia, E; Santacana, M; Stirbat, TV; Brochard-Wyart, F; Garcia, A; Alameda, F; Cabrera, S; Palacios, J; Moreno-Bueno, G; Abal, M; Thomas, W; Dufour, S; Matias-Guiu, X; Santamaria, A; Reventos, J; Gil-Moreno, A; Colas, E
Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early-stage endometrioid endometrial cancer
JOURNAL OF PATHOLOGY 241 475-487. .
-
Bosse, T; Nout, RA; McAlpine, JN; McConechy, M; Britton, H; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Matias-Guiu, X; Gilks, B; Soslow, R
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
LABORATORY INVESTIGATION 97 277-277. .
-
Bosse, T; Nout, RA; McAlpine, JN; McConechy, M; Britton, H; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Matias-Guiu, X; Gilks, B; Soslow, R
Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups
Modern Pathology 30 277-277. .
-
Ruiz, N; Vidal, A; Ponce, J; Marti, L; Rovira, J; Barahona, M; Piulats, JM; Llobeta-Navas, D; Santacana, M; Villanueva, A; Matias-Guiu, X
Patient-Derived Orthoxenografts (PDX) Reproduce Pathological Features of Corresponding Endometrial Carcinomas (EC)
LABORATORY INVESTIGATION 97 306-306. .
-
Ruiz, N; Vidal, A; Ponce, J; Marti, L; Rovira, J; Barahona, M; Piulats, JM; Llobeta-Navas, D; Santacana, M; Villanueva, A; Matias-Guiu, X
Patient-Derived Orthoxenografts (PDX) Reproduce Pathological Features of Corresponding Endometrial Carcinomas (EC)
Modern Pathology 30 306-306. .
-
Eritja, N; Chen, BJ; Rodriguez-Barrueco, R; Santacana, M; Gatius, S; Vidal, A; Marti, MD; Ponce, J; Bergada, L; Yeramian, A; Encinas, M; Ribera, J; Reventos, J; Boyd, J; Villanueva, A; Matias-Guiu, X; Dolcet, X; Llobet-Navas, D
Autophagy orchestrates adaptive responses to targeted therapy in endometrial cancer
Autophagy 13 608-624. .
-
van der Putten, LJM; van de Vijver, K; Bartosch, C; Davidson, B; Gatius, S; Matias-Guiu, X; McCluggage, WG; Toledo, G; van der Wurff, AAM; Pijnenborg, JMA; Massuger, LFAG; Bulten, J
Reproducibility of measurement of myometrial invasion in endometrial carcinoma
VIRCHOWS ARCHIV 470 63-68. .
Projects
- Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
- EPH Receptor Signaling in Endometrial Cancer
- Ajuts per a la contractació de personal investigador novell (FI)
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
- EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
- Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
- VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment